Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steve Yoelin

Optometrist Newport Beach, CA Medical Doctor

NPI 1710180781 CMS profile 668681

355 Placentia Ave, Newport Beach, CA 92663

Open in the dashboard

General payments

$4,096,858

3,161 records reported · program years 2019–2025

Research payments

$96,599

Paid to them · 18 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,019,042 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Steve Yoelin of Newport Beach, CA is reported in the CMS Open Payments database as having received $4,096,858 across 3,161 general payments and $96,599 in research payments paid to them. Separately, studies naming them as principal investigator received $2,019,042 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $748,289 432
2025 Research $43 2
2024 General $633,404 409
2023 General $607,177 352
2022 General $612,701 434
2022 Research $14,203 6
2021 General $624,917 543
2020 General $270,315 189
2020 Research $54,422 6
2019 General $600,055 802
2019 Research $27,931 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steve Yoelin
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Steve Yoelin were reported at $748,289. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Steve Yoelin Optometrist median Middle half National median
2019 $600,055 $159 $67–$371 $163
2020 $270,315 $72 $29–$165 $114
2021 $624,917 $125 $46–$292 $132
2022 $612,701 $162 $66–$374 $149
2023 $607,177 $177 $72–$406 $160
2024 $633,404 $188 $77–$427 $164
2025 $748,289 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $2,077,499 1,893 payments
  2. AbbVie, Inc. $1,990,248 1,150 payments
  3. Galderma Laboratories, L.P. $10,759 52 payments
  4. Endo Pharmaceuticals Inc. $8,898 12 payments
  5. Merz North America, Inc. $8,321 48 payments
  6. Botanix SB Inc $1,000 1 payment
  7. Revance Therapeutics, Inc. $102 4 payments
  8. Sientra, Inc. $30 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,712,509 567 payments
  2. Consulting Fee $1,076,087 192 payments
  3. Travel and Lodging $251,071 1,020 payments
  4. Food and Beverage $56,608 1,320 payments
  5. Education $584 62 payments
Products named General payments · program years 2019–2025
  1. BOTOX $1,677,949 1,077 payments
  2. BOTOX COSMETIC $452,520 478 payments
  3. KYBELLA $12,718 5 payments
  4. Xeomin Dermatology $4,893 20 payments
  5. SOFDRA $1,000 1 payment
  6. VUITY $223 3 payments
  7. DYSPORT $209 2 payments
  8. DYSPORT $206 2 payments
  9. Xeomin musculoskeletal $114 3 payments
  10. DAXXIFY $102 4 payments
  11. Other $171 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Allergan Inc. $96,384 13 payments
  2. AbbVie, Inc. $215 5 payments

Records

3,179 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record